GOOD buying opportunity,
While the USA is in later-stage clinical trials, EMD is gaining experience and RWD on actually delivering the clinical service and wrap-around support. I can see the USA doing a deal here once they have approval, as arguably we will have the most experience of any company globally (no one in the USA will have the skills as its only able to be done at the research level), and leverage that into our mdma analogs.
Australia is deff a number of years ahead of any counterpart. and just like cannabis we will quickly grow our dataset from 0 to >10,000.
Pax has some nice revenue as well.
- Forums
- ASX - By Stock
- EMD
- general talk
general talk, page-238
-
- There are more pages in this discussion • 109 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EMD (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $21.67M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 89097 | 4.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.4¢ | 45000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 8979 | 0.052 |
1 | 89097 | 0.049 |
1 | 52083 | 0.048 |
2 | 27020 | 0.046 |
3 | 110000 | 0.045 |
Price($) | Vol. | No. |
---|---|---|
0.054 | 45000 | 1 |
0.055 | 150000 | 1 |
0.058 | 13333 | 1 |
0.060 | 22554 | 1 |
0.062 | 25000 | 1 |
Last trade - 10.23am 03/07/2024 (20 minute delay) ? |
Featured News
EMD (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online